Product access
An additional dispensing pathway when the MIP lacks distribution access to the prescribed therapy.
Manufacturer Access & Patient Support
Therapies for
More Tomorrows.
Expand oncology access. Keep the patient connected to their treating practice.
SortPak serves as an extension of Medically Integrated Pharmacy (MIP), supporting an additional dispensing pathway when product access, payer restrictions, or reimbursement barriers prevent the MIP from filling.
Why give SortPak access?
When the MIP cannot dispense,
the care connection continues.
Manufacturer authorization can create another pathway for eligible patients. SortPak coordinates medication access and patient support alongside the referring practice, while the treating clinicians continue to direct therapy.
Read the manufacturer access story
Payer restrictions
Coordination of eligible options when coverage or network requirements limit where the MIP can dispense.
Reimbursement barriers
Support for an outside dispensing pathway that keeps the referring MIP involved in the medication journey.
The principle behind our model
Extend access.
Keep the MIP at the center.
Our mission
Expand access to oncology therapies through partnerships that support the MIP model and preserve the patient’s connection to the treating team.
Our vision
A connected oncology ecosystem where access barriers can be addressed while the oncology center retains treatment oversight.
National relationships. Individual access pathways.
A pathway tailored
to the patient’s benefit.
Our relationships with health plans, MSOs, and IPAs support coordination across Medicaid, commercial, and Medicare populations. Each patient’s pathway is reviewed against their coverage, prescribed therapy, and access requirements.
Medicaid
State- and plan-specific coverage, managed-care requirements, and prior authorization needs.
Commercial
Plan and network requirements, authorizations, and eligible copayment assistance options.
Medicare
Plan-specific coverage, authorization requirements, and available assistance pathways.
What happens after product authorization
Dedicated to the patient.
At every stage of therapy.
Our team works with the MIP and patient to confirm eligibility, navigate access requirements, coordinate dispensing and delivery, and remain engaged with refills and medication questions.
Prior authorization
Coordinate required information with the oncology office, track progress, and communicate the next step.
Copayment assistance
Review available copay programs and help eligible patients navigate enrollment and program requirements.
Patient assistance programs
Evaluate available pathways and support the application process, subject to program eligibility.
Pharmacist-led support
Medication review, interaction screening, patient education, and communication with the prescribing team.
Delivery coordination
Confirm arrangements with the patient and keep the oncology office informed about order and delivery progress.
Ongoing follow-through
Coordinate refill needs, respond to medication questions, and maintain communication with the referring MIP.
SortPak Live
The patient journey,
connected.
Keep the practice involved
Prior authorization status, case notes, order progress, delivery information, and direct messaging help the MIP stay connected to each referred patient.
Follow the access milestones
Manufacturer partners can agree on authorized access and dispensing milestones, therapy-specific REMS checkpoints, follow-up reporting, and reporting cadence.
Practice access is scoped to its patients and authorized team. Manufacturer visibility depends on program agreements, patient permissions, and applicable privacy requirements.
MIP Access Continuity Program
Why Give SortPak Access?
Help your therapy reach eligible patients.
Keep their oncology team connected.
For manufacturers
An additional pathway. A measurable purpose.
Reach eligible referrals when product access, payer restrictions, or reimbursement barriers prevent the MIP from dispensing. SortPak evaluates eligibility and coordinates access, dispensing, and ongoing support.
Together, define reporting for referral reasons, access resolution, time to dispensing, and practice updates.
For the MIP
Keep the practice involved.
The oncology team directs treatment. SortPak Live connects case notes, authorization and delivery updates, and direct communication.
For the patient
Support at every step.
Benefits review, authorization support, eligible financial assistance, pharmacist education, delivery, and refill coordination.
Manufacturer reporting is defined by program agreements, permissions, and applicable privacy requirements.
Proven launch experience. A connected care model.
Experience with complexity.
Commitment to the patient.
SortPak has successfully supported multiple limited-distribution medication launches, including therapies with REMS requirements. Our independent oncology focus and well over 20 years of team expertise support a practical commitment to the patient and referring practice.
URACSpecialty Pharmacy Accreditation
URACMail Service Pharmacy Accreditation
ACHCSpecialty Pharmacy Accreditation
NABPPharmacy Accreditation
Manufacturer partnerships
Give your therapy
a connected path forward.
Identify the access gap. Define the eligible referral pathway. Agree on patient services, program requirements, and reporting with the MIP connection built in.
Service availability is confirmed by state, product authorization, payer/network requirements, and patient eligibility. Assistance is subject to applicable program rules. Accreditation does not guarantee access to a particular product or network.